Orlistat mouth rinse: Using the tongue to deliver antiobesity medication in a double-blind randomized crossover pilot trial.

Primeaux SD, Dubin R, Greenway FL

Open source

DOI
10.1111/dom.15101
Published
2023 Aug
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.15101,
  title = {Orlistat mouth rinse: Using the tongue to deliver antiobesity medication in a double-blind randomized crossover pilot trial.},
  author = {Primeaux SD and Dubin R and Greenway FL},
  year = {2023},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.15101},
  url = {https://doi.org/10.1111/dom.15101}
}

RIS

TY  - JOUR
TI  - Orlistat mouth rinse: Using the tongue to deliver antiobesity medication in a double-blind randomized crossover pilot trial.
AU  - Primeaux SD
AU  - Dubin R
AU  - Greenway FL
PY  - 2023
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.15101
UR  - https://doi.org/10.1111/dom.15101
ER  - 

APA

SD, P., R, D., & FL, G. (2023). Orlistat mouth rinse: Using the tongue to deliver antiobesity medication in a double-blind randomized crossover pilot trial.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.15101

Source records